Yonatan Zunger Thank you for sharing your thoughts. You have inspired me to write what I have been meaning to speak out for years:
Basically, he was claiming that he is being discriminated against. All large companies have mechanisms to make such claims, because they are disruptive if made in public. No one with team management experience needs to be told this, but he has proven the point anyway: An all-points bulletin is not the way to make such claims. His actions have cost…
Uh, I would say that manifesto writer dude’s beliefs have a bit of rigid orthodoxy to them, and pretty badly outdated stuff too. I mean, it’s pretty extreme to just simply say, based on a bunch of nonsense, that women somehow can’t be as good engineers as men. That’s an orthodoxy if ever I heard of one.
He stated that he, as a senior member of the company in question, would fire the man that deliberately and decisively insulted some ~30% of their workforce, and ~50% of their client base. And he did this in so sloppy a fashion bad press is still being generated. What’s more, he did so for so feeble a reason as “hey guys, I’ve just been thinking”.
PhD != relevent knowlegde to all subjects. Here’s a point by point response…
The guy published a rambling, unsourced, easily disproved, opinion piece that glaringly illustrated his own insecurities and privileged point of view. Which is fine (in the first admendment sense). [Not fine from an employer POV if he actually read his employment agreement and the section on hostile workplace environment]
You have probably heard about the manifesto a Googler (not someone senior) published internally about, essentially, how women and men are intrinsically different and we should stop trying to make it possible for women to be engineers, it’s just not worth it.
Perhaps it will help if Temple-Wood knows that most intelligent educated men are horrified by the kind of abuse that she describes. The men who do that are really boys — not men — and they are deranged boys at that.
“ I ask myself, if I am diagnosed with toxoplasmosis, would I want a cheap 60-year old medicine that wasn’t being actively researched and improved, or would I chose a drug that was being invested in and improved, even if my insurance company forked over thousands for it?”